The impact of systemic inflammatory markers on EGFR-mutant non-small cell lung cancer
Inflammation could be one of the pathogenesis of both NSCLC and EGFRm lung cancer as we demonstrated in our pilot study. STAT3 is a potentially inflammatory-predictive biomarkers. Larger cohort is needed.
Authors
- D. Munthum
- Natini Jinawath (ORCID: https://orcid.org/0000-0002-3437-4698)
- Arthit Chairoungdua (ORCID: https://orcid.org/0000-0002-0965-126X)
- Ekaphop Sirachainan
- Pimpin Incharoen
- Putthapoom Lumjiaktase (ORCID: https://orcid.org/0000-0001-8013-6204)
- Thitiya Dejthevaporn (ORCID: https://orcid.org/0000-0003-1808-7303)
- Salin Amponnavarat
- M. Ngodngamtaweesuk
- Pimtip Sanvarinda (ORCID: https://orcid.org/0000-0003-2430-1580)
- Phichai Chansriwong (ORCID: https://orcid.org/0000-0002-2220-0068)
- Thanaporn Thamrongjirapat
- N. Monnamo
- Thanyanan Reungwetwattana (ORCID: https://orcid.org/0000-0002-3147-7640)
- Khantong Khiewngam
- Narumol Trachu
- Nattanan Reungwetwattana
- Passaworn Cheyasawan
- Supagone Wangsubtawee
Institutions
- Rajamangala University of Technology Isan (TH)
- Mahidol University (TH)
- Rajamangala University of Technology Suvarnabhumi (TH)
- Ramathibodi Hospital (TH)
- Srinakharinwirot University (TH)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-10-04
- DOI
- https://doi.org/10.1186/s12885-025-14915-1
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Mahidol University